Abbott India announced that the 80th Annual General Meeting(AGM) of the company will be held on 8 August 2024.Powered by Capital Market - Live News

Abbott India announced that the Board of Directors of the Company at its meeting held on 9 May 2024, inter alia, have recommended the final dividend of Rs 410 per equity Share (i.e. 4100%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Abbott India rose 24.04% to Rs 287.06 crore in the quarter ended March 2024 as against Rs 231.42 crore during the previous quarter ended March 2023. Sales rose 7.11% to Rs 1438.63 crore in the quarter ended March 2024 as against Rs 1343.08 crore during the previous quarter ended March 2023.For the full year,net profit rose 26.52% to Rs 1201.22 crore in the year ended March 2024 as against Rs 949.41 crore during the previous year ended March 2023. Sales rose 9.35% to Rs 5848.91 crore in the year ended March 2024 as against Rs 5348.73 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales1438.631343.08 7 5848.915348.73 9 OPM %22.9120.86 -24.8422.54 - PBDT407.87325.75 25 1688.921343.79 26 PBT389.68308.41 26 1617.751273.82 27 NP287.06231.42 24 1201.22949.41 27 Powered by Capital Market - Live News

Abbott India will hold a meeting of the Board of Directors of the Company on 9 May 2024.Powered by Capital Market - Live News

The Board of Abbott India has appointed Murari Ranganathan as Commercial Director - Women`s Health, Metabolics and International Business effective 02 May 2024. He will be part of the Senior Management team of the Company.Powered by Capital Market - Live News